Journal: Cellular & Molecular Biology Letters
Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer
doi: 10.1186/s11658-025-00846-z
Figure Lengend Snippet: Ilicicolin A alleviates enzalutamide resistance by RORC/GPX4 axis of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A, enzalutamide, and erastin on body weight of nude mice. C . In vivo measurement and recording of the tumor volume of ilicicolin A, enzalutamide, and erastin in nude mice. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance
Article Snippet: Experimental materials are listed below: N-cadherin (66219–1-Ig, Proteintech), vimentin (E-AB-18212, Proteintech), Snail (26183–1-AP, Proteintech), MMP2 (E-AB-40409, Proteintech), Parp-1 (13371–1-AP, Proteintech), AR (22089–1-AP, Proteintech), AR-V7 (68492S, Cell Signaling Technology), RORC (PA5-23148, Thermo Scientific), E-cadherin (20874–1-AP, Proteintech), c-Myc (10828–1-AP, Proteintech), cyclin D1 (26939–1-AP, Proteintech), cleaved caspase 7 (9491S, Cell Signaling Technology), GPX4 (67763–1-Ig, Proteintech), SLC7A11 (26864–1-AP, Proteintech), FTH1 (10727–1-AP, Proteintech), and GAPDH (60004–1-Ig, Proteintech).
Techniques: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot